Fingerprint
Dive into the research topics of 'Complement gene variant effect on relapse of complement-mediated thrombotic microangiopathy after eculizumab cessation'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Complement gene variant effect on relapse of complement-mediated thrombotic microangiopathy after eculizumab cessation
behalf of the Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy (CAP-TMA) Disease-Oriented Group
Research output: Contribution to journal › Article › peer-review